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We recently showed that inducible nitric oxide synthase conformational intermediates can be
resolved via FMN ﬂuorescence lifetimes. Here we show that neuronal NOS activation by calmodulin
removes constraints favoring a closed ‘input state’, increasing occupation of other states and facil-
itating conformational transitions. The 90 ps FMN input state lifetime distinguishes it from 4 ns
‘open’ states in which FMN does not interact strongly with other groups, or 0.9 ns output states in
which FMN interacts with ferriheme. Enablement of the conformational cycle is an important par-
adigm for control in nNOS and related enzymes, and may extend to other control modalities.
 2012 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Nitric oxide production by nitric oxide synthases consumes
three NADPH derived electrons per mol of NO in monooxygenase
reactions mediated by a heme containing oxygenase domain. The
endothelial and neuronal isoforms (eNOS and nNOS) are important
signal generators [1–3]. Eukaryotic NOS includes NADPH, FAD and
FMN binding domains [4–9].
Calcium–calmodulin (Ca2+/CaM) controls NO synthesis by eNOS
and nNOS by activating electron transfer [5]. Ca2+ controlled iso-
forms contain an autoinhibitory element (AI), present as an FMN
binding domain insertion, and C-terminal extension that inhibits
electron transfer [10–12]. Inducible NOS (iNOS) lacks an AI and
binds CaM at all physiological Ca2+ concentrations [13].
CaM activation of NOS [14–16] increases NADPH-cytochrome c
reductase activity and FMN ﬂuorescence [9,12,15,16]. In our teth-
ered shuttle mechanism the FMN binding domain dissociates from
an ‘input state’, reorienting to reduce the oxygenase domain [7,17–19]. Activation by CaM is the result of increased rates of conforma-
tional transitions, which should in general alter the conformational
distribution.
We recently showed that conformational states of iNOS and
iNOS constructs can be characterized by FMN ﬂuorescence life-
times [20]. Because of the lack of an AI, the shorter C terminal
extension, and differences in the CaM binding site, iNOS activity
is insensitive to Ca+2, and the effects of CaM binding on the confor-
mational manifold cannot be studied. Here we show that CaM acti-
vation changes the distribution of conformations characterized by
the environment of FMN.
2. Materials and methods
Puriﬁcation of nNOS was previously described [21,22]. Flavin
and heme were assessed spectrophotometrically; activity was
measured using oxyhemoglobin [22].
Fluorescence decays were recorded using a PicoQuant Fluoro-
time 100 TCSPC ﬂuorescence lifetime spectrometer [23], or a PTI
Picomaster TCSPC spectrometer [20]. FMN was excited at
440 nm using a pulsed laser diode with 20 MHz repetition; exci-
tation at 378 nm and 473 nm produced similar results. Emission
was detected through a polarizer oriented at 54.7 to excitation
polarization. Long-pass ﬁlters from Chroma Technology [Rocking-
ham, VT] were used to eliminate scattered light.
Fig. 1. Effect of calmodulin activation on ﬂuorescence decays of nNOS holoenzyme.
FMN was excited with a pulse from a 478 nm laser and the ﬂuorescence decay at
525 nm was observed at 25C. 1 lM nNOS in 50 mM MOPS buffer, pH 7.4, 50
mMNaCl with 10% glycerol.2 lM EDTA was added to remove trace calcium. h after
addition of 4 lM calmodulin Dafter the addition of 4 lM calmodulin and 20 lM
Ca2+.
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exponentials:
IðtÞ ¼
Xn
ii¼1
ai exp t=sið Þ ð1Þ
where the ai represent amplitudes and the si are decay times. The
fractional contribution of the ith component to the steady-state
intensity is:
fi ¼ aisiPjajsj ð2Þ
ai and si were determined as previously described [20].
3. Results and discussion
FMN ﬂuorescence is dominated by a broad emission peak near
525 nm, evoked by pumping isoalloxazine absorbance bands. We
recently showed that the weak ﬂuorescence of iNOS is due to
FMN quenching by FAD and ferriheme; the interactions are charac-
teristic of obligatory conformational intermediates in the catalytic
cycle [20]. FMN is reduced by FAD in a state in which the isoallox-
azines are in van der Waals contact, shown in crystal structures of
P450 reductase and nNOS reductase complex [24,25]. The isoallox-
azine dimer of this state has a very short 90 ps lifetime [20]. A
heterogeneous distribution of ‘open’ states with an average FMN
lifetime of 4.3 ns is the majority state in the two domain oxyFMN
construct and a minority state in holoenzyme.A state with an
FMN ﬂuorescence lifetime of 0.9 ns, attributed to quenching by
interaction with ferriheme, was observed using oxyFMN. Previous
studies with P450 and nNOS reported ﬂavin ﬂuorescence lifetimes
e.g., [26,27], but insights provided by structural and mechanistic
studies allow more productive interpretations.
Because CaM increases cytochrome c reduction, we expect in-
creased interconversion of the input state and nearby states in
which FMN is accessible to cytochrome c. Because NO synthesisis
undetectable without CaM, we expect interconversion of the input
and output states to be negligible in the absence of CaM, and fast
enough to support NO synthesis with CaM bound. Rate increases
usually change conformational distributions because equilibrium
constants are ratios of rate constants. Although we can’t directly
examine the kinetics of changes in ﬂuorescence decays, it is clear
from many previous kinetics papers that calmodulin binding in-
creases the rate of cytochrome c reduction and NO synthesis. This
is consistent with an increased rate of release of the FMN binding
domain, and not with a decreased rate of input state formation.
Fig. 1 shows ﬂuorescence decays of nNOS holoenzyme excited
at 478 nm. FMN ﬂuorescence emission at 525 nm decays as a mul-
tiple exponential (ﬁlled diamonds). Reasonable ﬁts to were ob-
tained with component lifetimes of 90 ps, 0.9 ns, and 4 ns, with
the 90 ps state accounting for 70% of the amplitude. Better ﬁts of
the long tail were obtained by replacing the 4 ns component with
distributions of states, suggesting that component is heteroge-
neous. These results are similar to those observed in iNOS [20], ex-
cept that 1 ns components could only be observed in iNOS in
truncated constructs. Calmodulin addition (square symbols) signif-
icantly decreased the 90 ps population, and increased the 0.9 ns
and 4 ns states. The effect of endogenous Ca2+ in the added CaM
(squares) is increased by excess Ca2+(triangles).
The CaM induced shift in the conformational poise of nNOS is
summarized in Table 1. The small output state population in nNOS
in the absence of CaM is probably real, but CaM activation pro-
duces a signiﬁcant population at the expense of the input state.
Although CaM binding and CaM activation are rapidly reversible
with EDTA, ﬂuorescence changes in response to EDTA are slow and
incomplete. EDTA addition produced a decay trace after ﬁve min-utes differing by only a few percent from the CaM activated trace.
Steady state FMN ﬂuorescence decays after EDTA addition with
half time of 30 min.
The reason for this apparent discrepancy is that CaM primarily
affects the rate of interconversion of conformations. An nNOS mol-
ecule that releases CaM cannot rapidly relax to other sections of
the conformational manifold.
The DG810 mutant of nNOS has a shortened loop along the edge
of the FMN binding domain that binds isoalloxazine, resulting in
reversal of FMN one electron couples and low NO synthase activity
[19]s. CaM binding does not increase DG810 cytochrome c reduc-
tase activity or steady state FMN ﬂuorescence. The mutant was
originally described as ‘already in an activated conformation’.
FMN ﬂuorescence lifetimes of DG810 are shown in Table 1;
some ﬁts include a small (5%) contribution from a 90 ps compo-
nent. Clearly, DG810 has conformational states similar to those of
wild type enzyme. Rather than having a single ‘activated’ confor-
mation, the mutant enzyme is better described as less constrained
than wild type enzyme. Whereas wild type nNOS favors the input
state, the mutant is much more capable of assuming open confor-
mations in the absence of CaM, likely because of weakened inter-
actions between the FMN and FAD domain interface [19]. The
increased steady-state ﬂuorescence of the mutant in the absence
of CaM is due to the higher ﬂuorescence yield of longer-lived sta-
tes.The Forster equation describing exciton transfer between tran-
sition dipoles in s1 is
kDA ¼ 8:78 1023JðkÞj2Q f t1D0n4R6
where J(k) is the spectral overlap integral, j2 = (ad-3(ar)(dr))2 is
the dipole orientation factor, Qf is the isolated quantum yield of
the donor, tD0is the isolated lifetime of the acceptor, n is the refrac-
tive index of the surroundings, and R is the effective donor–acceptor
distance in Ångstrom units. Because FMN emission overlaps ferri-
heme a and b bands, FRET readily accounts for quenching of FMN
ﬂuorescence in the output state, given the heme-FMN distance of
13–15 Ångstroms suggested by electron paramagnetic resonance
[17,20,28].
Table 1
FMN Fluorescence lifetimes for wild type nNOS and DG810 mutant showing the effect of CaM activation on the conformational manifold. In some experiments a small fraction
(5%) of input state conformation was observed in the DG810 mutant, and it is possible that small populations of the input state partially account for the shorter output state
lifetimes in the ﬁts presented here.
Sample A1 s1 (ns) A2 s2 (ns) A3 s3 (ns) Amplitude weighted lifetime (ns) x2
nNOS-full length 0.43 0.09 0.19 0.9 0.38 4.3 1.83 1.12
nNOS-full length + CaCAM 0.14 0.09 0.33 0.9 0.52 4.3 2.56 1.31
nNOS-HoloProtein DG-810 0.3 0.72 0.7 4.1 3.08 1.21
nNOS-HoloProtein DG810 + CaCaM 0.35 0.48 0.65 4.2 2.93 1.12
Fig. 2. Illustration of the conformational cycle of the FMN domain in NOS. Dissociation of the FMN domain from the input state initially produces a manifold of rapidly
equilibrating open states that are competent to reduce cytochrome c, accounting for rapid NADPH-cytochrome c reduction. To reduce the oxygenase domain, the FMN domain
must traverse a conformational bottleneck. Hence, NADPH-heme electron transfer is slow although both NADPH-cytochome c and heme-FMN electron transfers are rapid.
The open state manifold consists of a heterogeneous population of states that have relatively long FMN ﬂuorescence lifetimes; the input and output states are well deﬁned.
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yield of free FMN, with a lifetime of 4–5 ns, is therefore 20–30%,
and small ﬂavoproteins lacking strong quenchers are similar [24].
Isolated NOS FMN binding domain has a majority component with
a lifetime of 4.3 ns, and like the open states of holoenzyme has
quantum yield of 25%. The quantum yield of the 0.9 ns output
state is 6%, and the quantum yield of the 90 ps input state is
<1%. The input state, in which FAD and FMN are in van der Waals
contact, might be better described as a chromophoric dimer.
Fig. 2 illustrates conformational states and transitions of the
FMN domain in the catalytic cycle of the reductase unit. In the in-
put state (far left) FMN is buried in the interior of a diﬂavin reduc-
tase complex, in contact with donor FAD but isolated from acceptor
heme. In the output state, the FMN binding domain is associated
with the heme-containing oxygenase domain. There are open con-
formations in rapid equilibrium on the time scale of electron trans-
fer with both the input and output states [20], and electron
delivery to the oxygenase catalytic site is limited by passage
through a conformational bottleneck. Solid arrows indicate transi-
tions enhanced by CaM binding to wild type nNOS, with the direc-
tion of the arrow representing the direction favored by CaM. The
open arrows indicate the shifts in population in DG810 relative
to wild type. Note that the lifetimes of some states don’t corre-
spond exactly to the wild type components. The geometries of
these states may be altered, and short lifetime states may have
contributions from uncoupled FAD (FAD not in contact with
FMN). Preparations lacking FAD have well deﬁned input and out-
put state components [20].Dunford et al. [29] presented interesting and previously unde-
tected CaM binding induced changes in midpoint potentials of
cofactors and observed changes in FMN ﬂuorescence in stopped
ﬂow experiments. They associate increased FMN ﬂuorescence with
increased solvent exposure; the lower ﬂuorescence they observe
on NADP+ addition more likely is due to FAD quenching of FMN
than shielding from solvent. Hence, NADP+ analogs decrease con-
formational mobility rather than promoting it as CaM does. It ap-
pears likely that their midpoint potential changes are coupled to
the conformational shifts we observe; differences between NOS
preparations may reﬂect different occupation of the conforma-
tional manifold prior to CaM addition in addition to proteolytic ef-
fects. The experiments presented here use fully oxidized enzyme
because the oxidized ﬂavins have well characterized ﬂuorescence
spectra, and the changes we observe can be attributed to confor-
mational effects rather than a complex mixture of conformational
and redox events. The turnover cycle proceeds through one to
three electron reduced states, and we expect conformational
events to be weakly coupled to redox events and strongly coupled
to ligand (e.g. NADP+) binding.
The experiments presented here show that calmodulin binding
to nNOS produces a major shift in conformational equilibrium. This
change indicates an increase in the diversity of conformations
rather than the occupation of a single ‘active’ state, supporting a
shuttle mechanism in which the enzyme moves through a series
of large-scale conformational changes. The mechanism of CaM
activation is a theme likely to be echoed by other regulatory inputs
that activate or inhibit NOS.
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